article thumbnail

These 10 biotech companies are changing how we discover new drugs and treat complex diseases

Fast Company Tech

The study, which is open to babies born at New York-Presbyterian Hospitals, has sequenced more than 17,000 newborns to date. GeneDx has also partnered with the New York Center for Rare Diseases at Montefiore,PacBio, and Google Health to deliver genetic diagnoses forBronxfamilies living with rare diseases.

article thumbnail

C2i, a genomics SaaS product to detect traces of cancer, raises $100M Series B

TechCrunch

If you or a loved one has ever undergone a tumor removal as part of cancer treatment, you’re likely familiar with the period of uncertainty and fear that follows. Will the cancer return, and if so, will the doctors catch it at an early enough stage? The biggest question in cancer treatment is, ‘Is it working?’

Cancer 95
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What do the mega gifts of 2024 say about giving? 

Candid

and his daughter, Tessa Stephenson Brand, in support of pancreatic cancer research. Golisano has long been a major donor to organizations in upstate New York , especially those working with people with developmental disabilities. In the area of health and medical research, City of Hope received $150 million from A.

Gift 98
article thumbnail

Isabl’s rapid whole-genome analysis opens the playbook for cancer treatment

TechCrunch

Every cancer is unique because every person is unique, and one of the most important weapons in any cancer battle is information. Isabl offers that in abundance through rapid sequencing of cancer cells’ entire genomes, potentially showing which therapies will and won’t be effective within days.

Cancer 85
article thumbnail

From improving cancer treatments to saving the bees, these are the companies in IndieBio’s latest class

TechCrunch

Ultra-precise cancer therapies! IndieBio initially operated solely out of San Francisco, with the accelerator expanding just last year to include a New York cohort that runs in parallel. The SF program is led by Managing Director Po Bronson, while the New York program is led by Managing Director Stephen Chambers.

Cancer 104
article thumbnail

New drug reverses diabetes in mice, boosting insulin-making cells by 700%

TechSpot

Scientists from Mount Sinai Health System in New York City and the Los Angeles-based City of Hope, a research center for diabetes and one of the largest cancer research and treatment organizations in the US, have demonstrated a combination treatment that can increase human insulin-producing beta cells in vivo for.

article thumbnail

Forward Health raises $225M from investors including The Weeknd as it looks to expand nationwide

TechCrunch

markets including LA, New York, Chicago, SF and Washington, D.C., I spoke to Forward Health co-founder and CEO Adrian Aoun about his company’s plans for this fresh capital, and we also chatted briefly about how The Weeknd got involved. Forward, which currently operates clinics in select U.S. Image Credits: Forward Health.

Cancer 141